A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications.
Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and analysis and management services. It highlights the top 13 companies that generated revenue from these solutions between 2021 and 2024.
The global market was valued at about $3.8 billion in 2023. Frost & Sullivan projects annual growth of between 12% to 15% over the next few years, and expects the user base to increase 10% to 12% annually but average per-user prices to continue to decline amid intense competition. Solution providers will need more value-added features to increase their per-user income.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.